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Abstract
Background: Evidence suggests that low birth weight and fetal exposure to extreme maternal
undernutrition is associated with cardiovascular disease in adulthood. Hyperemesis gravida-
rum, a clinical entity characterized by severe nausea and excess vomiting leading to a subopti-
mal maternal nutritional status during early pregnancy, is associated with an increased risk of
adverse pregnancy outcomes. Several studies also showed that different measures related to
hyperemesis gravidarum, such as maternal daily vomiting or severe weight loss, are associated
with increased risks of adverse fetal pregnancy outcomes. Not much is known about long-term
offspring consequences ofmaternal hyperemesis gravidarum and relatedmeasures during preg-
nancy. We examined the associations of maternal daily vomiting during early pregnancy, as a
measure related to hyperemesis gravidarum, with childhood cardiovascular risk factors.
Methods: In a population-based prospective cohort study from early pregnancy onwards among
4,769 mothers and their children in Rotterdam, the Netherlands, we measured childhood body
mass index, total fat mass percentage, android/gynoid fat mass ratio, preperitoneal fat mass area,
blood pressure, lipids, and insulin levels. We used multiple regression analyses to assess the asso-
ciations of maternal vomiting during early pregnancy with childhood cardiovascular outcomes.
Results: Compared with the children of mothers without daily vomiting during early preg-
nancy, the children of mothers with daily vomiting during early pregnancy had a higher child-
hood total body fat mass (difference 0.12 standard deviation score [SDS]; 95% confidence
interval [CI] 0.03–0.20), android/gynoid fat mass ratio (difference 0.13 SDS; 95% CI 0.04–
0.23), and preperitoneal fat mass area (difference 0.10 SDS; 95% CI 0–0.20). These associations
were not explained by birth characteristics but partly explained by higher infant growth.
Maternal daily vomiting during early pregnancy was not associated with childhood blood pres-
sure, lipids, and insulin levels.
Conclusions:Maternal daily vomiting during early pregnancy is associated with higher child-
hood total body fat mass and abdominal fat mass levels, but not with other cardiovascular risk
factors. Further studies are needed to replicate these findings, to explore the underlying mech-
anisms and to assess the long-term consequences.
Introduction
Maternal undernutrition during pregnancy may lead to increased risks of cardiovascular disease
in the offspring in later life.1 This hypothesis is mainly based on studies linking low birth weight
and fetal exposure to extreme maternal undernutrition to the development of diseases in adult-
hood.2–4 Whether suboptimal maternal nutritional status during pregnancy in contemporary
populations also directly affects the development of cardiovascular risk factors in the offspring
remains unclear.
Hyperemesis gravidarum, a clinical entity affecting approximately 0.3–3.6% of all pregnan-
cies, is characterized by severe nausea and excess vomiting leading to a suboptimal maternal
nutritional status during early pregnancy and is associated with an increased risk of adverse
pregnancy outcomes.5–15 Hyperemesis gravidarum represents the extreme of the spectrum of
maternal excess vomiting and extreme nausea during early pregnancy. Several studies also
showed that different measures related to hyperemesis gravidarum, such as maternal daily vom-
iting or severe maternal weight loss, are associated with increased risks of adverse pregnancy
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outcomes, including preterm birth and small size for gestational
age at birth.16–18 A previous study among 3,165 Dutch mothers
and their children suggested that maternal hyperemesis gravida-
rum, which was measured as severe weight loss during early preg-
nancy, was associated with a higher blood pressure in childhood.18
No differences were present in childhood body mass index, glu-
cose, triglycerides, total cholesterol, high-density lipoprotein
(HDL), and low-density lipoprotein (LDL)-cholesterol. In this
study, no information about maternal vomiting during early preg-
nancy was available.
Based on these previous findings, we hypothesized that the chil-
dren of mothers with daily vomiting during early pregnancy may
also have a higher risk of adverse cardiovascular outcomes in child-
hood. Daily maternal vomiting may lead to suboptimal maternal
nutritional status, whichmay subsequently lead to suboptimal fetal
nutrient supply and developmental adaptations in response to a
suboptimal fetal environment.2,3 These fetal developmental
adaptations may permanently affect fetal growth, fetal adipocyte
development and fat deposition and structure, and the function
of cardiovascular organs. Thismay subsequently lead to an increased
risk of adverse birth outcomes and obesity and adverse cardio-
vascular outcomes in childhood and adulthood.19,20 Therefore, we
examined, in a population-based prospective cohort study among
4,769 mothers and their children, the associations of maternal vom-
iting during early pregnancy with childhood body mass index, total
body fat mass, android/gynoid fat mass ratio, abdominal preperito-
neal fatmass area, blood pressure, lipids and insulin levels, measured
at 6 years. We also explored whether these associations were
explained by maternal, birth, or childhood characteristics.
Methods
Study design
This study was embedded in the Generation R Study, a population-
based prospective cohort study from early fetal life onwards in
Rotterdam, the Netherlands.21,22 The study was approved by the
local Medical Ethical Committee (MEC 198.782/2001/31).
Pregnant women were enrolled between 2001 and 2005. Written
informed consent was obtained from all participating mothers.
In total, 8,879 mothers were enrolled during pregnancy. From
our analyses, we excluded those who enrolled after 22 weeks of
gestation (n= 581) and those who did not have information on
vomiting during early pregnancy available (n= 1,338). Of the
included women, 6,778 delivered singleton live born children, of
which 4,769 mothers and their children had childhood follow-
up measurements available (Fig. 1).
Maternal vomiting and nausea during early pregnancy
Information on maternal vomiting and nausea during early preg-
nancy was obtained via questionnaires at enrollment in the study.21
Maternal vomiting and nausea was reported in five categories
based on the number of times that pregnant women vomited or
had nausea during early pregnancy: daily; a few days a week; once
a week; less than once a week; never. We compared maternal daily
vomiting during early pregnancy, an indicator of hyperemesis
gravidarum, with other maternal vomiting categories. This
approach is in line with previous studies.6–13,23 Primary analyses
were performed using maternal vomiting, and sensitivity analyses
were performed using maternal nausea, across similar categories,
instead of maternal vomiting to examine whether the associations
differed between maternal vomiting and maternal nausea.
Childhood adiposity and cardiovascular outcomes
All children were invited for detailed body fat and cardiovascular fol-
low-upmeasurements at the age of 6.Wemeasured height andweight
without shoes and heavy clothing at a dedicated research facility.
Height was measured to the nearest millimeter with a stadiometer
(Holtain Limited, Crosswell, Crymych, UK). Weight was measured
to the nearest gram using an electronic scale (SECA 888, Almere,
The Netherlands), and body mass index (kg/m2) was calculated.24
Total body fat mass was measured with a dual-energy X-ray
absorptiometry (DXA) scanner (iDXA, General Electrics –
Lunar, 2008, Madison, WI, USA) and analyzed with the Encore
software v.12.6.25 DXA can accurately detect whole-body fat mass
within <0.25% coefficient of variation. Total body fat mass (kg)
was calculated as a percentage of total body weight (kg) measured
by DXA. Android/gynoid fat mass ratio was also calculated, which
reflects the waist-to-hip ratio.26
Preperitoneal fat mass was used as a proxy for visceral fat and
was measured using abdominal ultrasound examinations with
ultrasound LOGIQ E9 (GE Medical System, Wauwatosa, WI,
USA) and ATL-Philips Model HDI 5000 (Seattle, WA, USA), as
described in detail previously.27–29 Briefly, a linear (L12-5 MHz)
transducer was placed perpendicular to the skin surface on the
median upper abdomen. We scanned longitudinally from the
xiphoid process to the navel along the midline (linea alba).
Preperitoneal fat mass areas were measured as areas of 2 cm length
along the midline starting from the reference point in direction of
the navel.27
We measured systolic and diastolic blood pressure at the right
brachial artery, four times with 1-min intervals, using a validated
automatic sphygmanometer (Datascope Accutor Plus™; Paramus,
NJ, USA).30 A cuff was selected with a cuff width approximately
40% of the arm circumference and long enough to cover 90% of the
arm circumference. We calculated mean systolic and diastolic blood
pressure values using the last three blood pressure measurements.
We obtained 30-min fasting venous blood samples andmeasured
total cholesterol, low-density lipoprotein cholesterol, high-density
lipoprotein cholesterol, triglycerides, insulin, and C-peptide levels,
using Cobas 8000 analyzer (Roche, Almere, the Netherlands).
Covariates
Maternal age and prepregnancy weight were obtained at enrol-
ment. Maternal height (cm) was measured and prepregnancy body
mass index (kg/m2) was calculated. We defined gestational weight
gain as the difference between weight before pregnancy and
weight measured at 30 weeks of gestation (median 30.2; 95% range
28.5–32.6).21 Information on maternal educational level, ethnicity,
parity, smoking, and folic acid supplement use was obtained via
questionnaires. First-trimester nutritional intake was recorded
via a food frequency questionnaire.31 Information on pregnancy
complications, mode of delivery, gestational age, length and weight
at birth, and sex was available from medical records.32,33 We con-
structed gestational age-adjusted standard deviation scores (SDS)
for birth weight using North European growth standards.34 These
gestational age-adjusted SDS for birth characteristics represent the
equivalent of z-scores. Infant growth was measured in community
health centers according to standardized procedures at 24 months
(median 24.8 months; 95% range 23.4–28.1).21 We created age-
and sex-adjusted SDS of these infant anthropometrics within
our study population using Dutch reference growth charts.35 We
obtained information about breastfeeding, TV watching, and
timing of introduction of solid foods via questionnaires.21
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Statistical analysis
First, we examined differences in subject characteristics between
mothers with and without daily vomiting during early pregnancy
with ANOVA and chi-squared tests. Second, to provide further
insight into the correlation ofmeasures related to hyperemesis grav-
idarum with maternal weight, nutritional status, and birth
outcomes, we assessed the associations between maternal daily
vomiting and nausea during early pregnancy with multiple param-
eters of maternal nutritional status and birth outcomes using
univariate linear regression models. Third, we examined the associ-
ations of maternal daily vomiting during early pregnancy with
childhood outcomes and the role of potential mediators using linear
regression models. For these analyses, we used different linear
regression models: (1) A basic model including child’s age and
sex. (2) A confoundermodel, which additionally included covariates
selected on their associations with the outcomes of interest or a
change in effect estimate >10%. Covariates included were maternal
age, educational level, ethnicity, prepregnancy weight, parity, smok-
ing, folic acid supplement use, diet, delivery mode, and pregnancy
complications. We included childhood height as a covariate in all
models focusing on fat mass outcomes. (3) Intermediate models,
which additionally included potential intermediates (gestational
weight gain; birth characteristics including gestational age and
weight at birth; infant growth from birth until 2 years of age; and
infant lifestyle including breastfeeding duration, age at introduction
of solid foods, and TVwatching). (4) A fully adjusted model includ-
ing all confounders and all potential intermediate covariates.
Supplementary Figure S1 depicts an overall conceptual model with
all potential confounders and intermediate covariates for clarifica-
tion on the strategy of analysis and for interpretation of the results.
For all analyses, non-normally distributed childhood outcome var-
iables were log-transformed.We constructed SDS values ([observed
value –mean]/SD) for childhood outcomes to enable a comparison
of effect estimates. Since no significant interactions with fetal sex
and birth weight were present after taking into account multiple
testing, no further stratified analyses were performed. We per-
formed sensitivity analyses by comparing maternal daily vomiting
with never vomiting; by assessing a dose–response relationship
using maternal vomiting categories as a continuous variable, from
category “never” up to category “daily”; and by performing similar
analyses using daily nausea during early pregnancy. In order to
reduce potential bias associated with missing data and to maintain
statistical power, we performed multiple imputations of missing
covariates by generating five independent datasets using the
Mothers enrolled during pregnancy   
n = 8,879
Mothers included before the 22nd
week of pregnancy with information 
on vomiting.
n = 6,960
Mothers included before the 22nd
week of pregnancy with information 
on vomiting and with singleton life 
born children
n = 6,778
Childhood cardiovascular development at age of 6 years:
n = 4,769
Adiposity outcomes
Body mass index: n = 4,760
Body fat distribution: n = 4,627
Cardiovascular outcomes
Blood pressure: n = 4,370
Cholesterol: n = 3,152
HDL cholesterol: n = 3,157
LDL cholesterol: n = 3,154
Triglycerides: n = 3,143
Insulin: n = 3,126
C-peptide: n = 3,135
Excluded due to non-singleton life 
births, or no postnatal follow-up       
n = 182
Excluded due to missing information 
on vomiting in early pregnancy  
n = 1,338
Excluded due to no participation in 
follow up studies 
n = 2,009
Excluded due to a gestational age 
over 22 weeks 
n = 581
Mothers included until the gestational 
age of 22 weeks
n = 8,298
Fig. 1. Flow chart of the study population.
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Markov Chain Monte Carlo method after which the pooled effect
estimates were calculated. All analyses were performed using
SPSS version 21.0 for Windows (SPSS Inc, Chicago, IL, USA).
Results
Subject characteristics
The characteristics of included participants are shown in Table 1.
In total, 5.2% of all women vomited daily during early pregnancy.
Compared with mothers without daily vomiting during early preg-
nancy, mothers with daily vomiting during early pregnancy were
younger, more frequently less educated, and more frequently of
non-European origin (p < 0.05). Results of the non-response
analysis are shown in Supplemental Table S1. Compared with
mothers included in the analyses, those lost to follow-upweremore
likely to be older, less educated, and more often vomited daily dur-
ing early pregnancy; their children had a lower gestational age at
birth, lower birth weight, and were less frequently breastfed.
Univariate associations of maternal daily vomiting and nausea
during early pregnancy with maternal weight status were studied
using multiple parameters of maternal nutritional status and birth
outcomes shown in Supplementary Tables S2, S3, and S4. Maternal
daily vomiting and nausea during early pregnancy was associated
with a higher maternal prepregnancy weight and BMI, but with
lower total gestational weight gain. No significant differences in tri-
mester-specific weight gain were present. Among the women with
daily vomiting and nausea during early pregnancy, total caloric, fat,
and protein intakes tended to be lower, compared with women
without daily vomiting and nausea during early pregnancy. The
children of mothers with daily vomiting during early pregnancy
had a lower birth weight and a lower gestational age at birth, com-
pared with the children of mothers without daily vomiting during
early pregnancy. These effects were weaker for maternal daily nau-
sea during early pregnancy.
Maternal vomiting and childhood adiposity outcomes
Table 2 shows the associations ofmaternal daily vomiting during early
pregnancy with childhood body fat distribution at the age of 6. In the
confounder model, compared with the children of mothers without
daily vomiting during early pregnancy, the children of mothers with
daily vomiting during early pregnancy had a higher childhood total
body fat mass (difference 0.12 SDS; 95% confidence interval [CI]
0.03–0.20), android/gynoid fat mass ratio (difference 0.13 SDS; 95%
CI 0.04–0.23), and abdominal preperitoneal fat mass area (difference
0.10 SDS; 95% CI 0–0.20), but no significant difference in childhood
body mass index was present (difference 0.07 SDS; 95% CI –0.02 to
0.16). Additional adjustment for birth characteristics did not explain
the observed associations, but adjustment for infant growth slightly
attenuated the associations. In the fully adjustedmodel,maternal daily
vomiting during early pregnancy was associated with a higher child-
hood body mass index, total body fat mass, android/gynoid fat mass
ratio, and preperitoneal fat mass (p< 0.05). The effect estimates were
not affected when we restricted the analyses to daily vomiting versus
never vomiting only. Supplementary Table S5 shows that in the dose–
response analysis, only maternal daily vomiting during early preg-
nancy was associated with higher childhood body fat mass measures.
Also, similar tendencies were observed when using daily nausea dur-
ing early pregnancy instead of daily vomiting (results not shown).
Maternal vomiting and childhood cardiovascular risk factors
Table 3 shows that in the basic model, the children of mothers with
daily vomiting during early pregnancy had a higher systolic blood
pressure, but not diastolic blood pressure, compared with the chil-
dren of mothers without daily vomiting during early pregnancy
(difference in systolic blood pressure: 0.11 SDS; 95% CI 0.01–
0.20). Additional adjustment for confounding factors attenuated
the associations into non-significant. No differences were observed
in childhood total cholesterol, triglycerides, and insulin levels
between the children of mothers with or without daily vomiting
during early pregnancy. Supplementary Table S6 shows that in
the dose–response analysis, no associations of maternal daily vom-
iting during early pregnancy with childhood cardiovascular mea-
sures were present.
Discussion
In this prospective cohort study, we observed that daily maternal
vomiting during early pregnancy was associated with a higher
childhood total body fat mass, android/gynoid fat mass ratio,
and abdominal preperitoneal fat mass. These associations were
not explained by birth characteristics, but partly explained by
higher infant growth rates. We did not observe associations of
maternal daily vomiting during early pregnancy with childhood
blood pressure, lipids levels, or insulin levels.
Methodological considerations
We used a population-based prospective cohort design involving a
large number of subjects who we studied from early fetal life
onwards. Information on vomiting during early pregnancy was
available for 6,960 mothers, of which 4,769 mothers and their chil-
dren participated in childhood follow-up measurements. Mothers
without offspring follow-up data available were more often less
educated and from non-European descent, and more often vom-
ited daily during early pregnancy. The observed associations would
be biased if the associations of maternal vomiting during early
pregnancy with childhood outcomes differed between those
included and those exempted in the analyses. This seems unlikely,
but cannot be excluded. However, our study groupmight indicate a
selection toward a relatively healthy population, which could affect
the generalizability of our results.We used daily maternal vomiting
as an indicator of hyperemesis gravidarum. This approach is in line
with previous observational studies.6–13,23 This indicator is one
component related to hyperemesis gravidarum, but does not fully
reflect a severe clinical diagnosis of hyperemesis gravidarum,
which includes dehydration, hospitalization, electrolyte imbalance,
nutritional deficiencies, and maternal weight loss. We observed
that mothers with daily vomiting during early pregnancy had a
lower total gestational weight gain and a lower total caloric intake.
Due to the small number of mothers who vomited daily or had
nausea and reported severe weight loss, we were not able to assess
the associations of these combined maternal characteristics with
childhood outcomes in our study. However, additional adjustment
for gestational weight gain did not explain the observed associa-
tions of maternal daily vomiting or nausea with childhood out-
comes. Further studies are needed to assess the associations of a
clinical diagnosis of hyperemesis gravidarum as well as other
maternal characteristics relating to hyperemesis gravidarum with
long-term offspring consequences. Detailed information about
several maternal and childhood sociodemographic and lifestyle-
related factors was available in this study. Extensive adjustment
for these sociodemographic and lifestyle-related determinants in
our analyses did not explain the associations of maternal daily
vomiting during early pregnancy with childhood body fat out-
comes. However, because of the observational design, residual
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Table 1. Maternal and childhood characteristics (N= 4,769)1







Age, years 30.6 (4.9) 28.1 (5.0) <0.05
Height, cm 168.3 (7.2) 165.0 (7.3) <0.05
Weight, kg 66.3 (12.3) 67.5 (14.4) 0.06
Body mass index, kg/m2 23.4 (4.1) 24.9 (5.0) <0.05
Total gestational weight gain, kg 15.4 (5.5) 12.6 (6.7) <0.05
Gestational age at intake, weeks 14.3 (2.9) 14.6 (2.9) <0.05
Parity (nulliparous), % 60.1 52.7 <0.05
Education (higher education), % 50.3 20.9 <0.05
Ethnicity (European), % 67.1 33.9 <0.05
Smoking during pregnancy (yes), % 25.3 24.8 0.26
Folic acid supplement use (yes), % 79.6 57.0 <0.05
Total energy intake, kcal 2,069 (545) 1,945 (617) <0.05
Daily nausea during early pregnancy, % 26.7 94.1 <0.05
Pregnancy complications
Gestational hypertensive disorders, % 6.1 6.5 0.74
Gestational diabetes, % 0.9 1.6 0.15
Birth and infant characteristics
Gestational age at birth, weeks 39.9 (1.7) 39.8 (1.7) <0.05
Birth weight, g 3443 (547) 3364 (532) <0.05
Gestational age-adjusted birth weight (SDS) –0.06 (0.99) –0.19 (0.98) <0.05
Male sex, % 49.7 51.6 0.43
Cesarean delivery, % 12.6 10.2 0.14
Breastfeeding duration, months 4.6 (3.9) 3.9 (3.7) <0.05
Introduction of solid foods (before 6 months), % 89.4 88.7 0.17
Television watching (>2 hours/day), % 17.3 33.9 <0.05
Child characteristics
Age at follow-up, years 6.2 (0.5) 6.3 (0.7) <0.05
Infant weight growth from birth until 2 years, g 9,581 (1440) 9,838 (1712) <0.05
Body mass index, kg/m2 16.2 (1.8) 16.8 (2.4) <0.05
Total body fat mass, % 0.25 (0.06) 0.27 (0.06) <0.05
Android/gynoid fat mass ratio, % 0.25 (0.06) 0.27 (0.08) <0.05
Abdominal preperitoneal fat mass area, cm2 0.45 (0.44,0.46) 0.54 (0.51,0.58) <0.05
Systolic blood pressure, mmHg 102.4 (8.1) 103.8 (8.8) <0.05
Diastolic blood pressure, mmHg 60.5 (6.7) 61.4 (7.3) <0.05
Cholesterol, mmol/L 4.2 (0.6) 4.2 (0.6) 0.69
HDL-cholesterol, mmol/L 1.3 (0.3) 1.4 (0.3) 0.13
LDL-cholesterol, mmol/L 2.4 (0.6) 2.4 (0.5) 0.61
Triglycerides, mmol/L 1.1 (1.0,1.1) 1.1 (1.0,1.1) 0.71
Insulin, pmol/L 137.9 (134.2,141.5) 146.5 (134.1,158.9) 0.16
C-peptide, nmol/L 1.0 (1.0,1.1) 1.0 (1.0,1.1) 0.93
1Values represent mean (standard deviation), median (95% range), or percentages. Differences in subject characteristics between the groups were evaluated using one-way ANOVA for
continuous variables and chi-squared tests for proportions.
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confounding due to other sociodemographic and lifestyle-related
determinants, such as residential area, maternal physical activity
or sedentary lifestyle and childhood nutritional intake, might still
be an issue.
Interpretation of main findings
An accumulating body of evidence suggests that suboptimalmater-
nal nutrition during early pregnancy leads to an increased risk of
cardiovascular disease in later life of the offspring.1 Low birth
weight or fetal exposure to extreme maternal undernutrition is
associated with cardiovascular and metabolic diseases in
adulthood.2,3 Less is known about the long-term effects of milder
and more common suboptimal maternal nutritional status during
pregnancy.
Hyperemesis gravidarum, characterized by severe nausea and
excess vomiting during early pregnancy, resulting in electrolyte,
fluid, and nutrition imbalances and deficiencies, is a marker of sub-
optimal maternal nutritional status during early pregnancy.36–38
Previous studies have shown that hyperemesis gravidarum
might lead to an increased risk of adverse outcomes during
pregnancy.5–15 A study among 71,468 Norwegian mothers showed
that children from hyperemetic mothers – defined as enduring nau-
sea and vomiting starting before the 25th gestational week leading to












Basic model2 0.25 (0.16, 0.35)* 0.33 (0.24, 0.41)* 0.26 (0.16, 0.35)* 0.24 (0.14, 0.34)*
Confounder model3 0.07 (–0.02, 0.16) 0.12 (0.03, 0.20)* 0.13 (0.04, 0.23)* 0.10 (0, 0.20)*
Mediator models4
Gestational weight gain 0.10 (0, 0.19)* 0.12 (0.04, 0.21)* 0.14 (0.04, 0.23)* 0.11 (0.01, 0.22)*
Birth characteristics 0.08 (–0.01, 0.17) 0.12 (0.03, 0.20)* 0.13 (0.03, 0.23)* 0.10 (0, 0.21)*
Infant growth 0.06 (–0.03, 0.14) 0.10 (0.02, 0.18)* 0.12 (0.02, 0.21)* 0.09 (–0.02, 0.19)
Infant lifestyle 0.07 (–0.02, 0.16) 0.12 (0.03, 0.20)* 0.13 (0.03, 0.23)* 0.10 (0, 0.20)*
Fully adjusted model5 0.08 (0, 0.17)* 0.12 (0.03, 0.20)* 0.11 (0.02, 0.21)* 0.10 (0, 0.20)*
1Values are regression coefficients (95% confidence intervals) that reflect the difference for each body fatmeasure per standard deviation score change between the children ofmothers with and
without daily vomiting during early pregnancy. Estimates are based on multiple imputed data.
2Basic model is adjusted for child’s sex and age at outcome measurements.
3Confounder models include maternal age, educational level, ethnicity, prepregnancy weight, parity, smoking, folic acid supplement use, diet, delivery mode, and pregnancy complications.
Models for fat mass are additionally adjusted for childhood height.
4Intermediate models are additionally adjusted for each potential intermediate (1. gestational weight gain; 2. birth characteristics: gestational age at birth and birth weight; 3. infant growth:
growth from birth until 2 years of age; 4. infant lifestyle: breastfeeding duration, age at introduction of solid foods, and TV watching).
5Fully adjusted models include all potential confounders and intermediates.
*P < 0.05.
Table 3. Maternal daily vomiting during early pregnancy and childhood cardiovascular risk factors (N= 4,370)1













Basic model2 0.11 (0.01, 0.20)* 0.09 (–0.01, 0.19) 0 (–0.12, 0.12) 0.03 (–0.09, 0.15) 0.07 (–0.05, 0.19)
Confounder model3 0.03 (–0.08, 0.12) 0.02 (–0.09, 0.12) –0.04 (–0.16, 0.09) 0.03 (–0.09, 0.16) 0.07 (–0.05, 0.20)
Mediator models4
Gestational weight gain 0.03 (–0.08, 0.13) 0.03 (–0.07, 0.14) –0.04 (–0.16, 0.09) 0.02 (–0.11, 0.15) 0.09 (–0.04, 0.22)
Birth characteristics 0.02 (–0.08, 0.12) 0.01 (–0.09, 0.11) –0.04 (–0.16, 0.08) 0.03 (–0.10, 0.15) 0.07 (–0.05, 0.20)
Infant growth 0.02 (–0.08, 0.12) 0.01 (–0.09, 0.11) –0.04 (–0.16, 0.09) 0.03 (–0.09, 0.16) 0.07 (–0.06, 0.19)
Infant lifestyle 0.03 (–0.08, 0.13) 0.01 (–0.09, 0.11) –0.04 (–0.16, 0.08) 0.03 (–0.09, 0.16) 0.08 (–0.05, 0.20)
Fully adjusted model5 0.02 (–0.08, 0.12) 0.03 (–0.08, 0.13) –0.04 (–0.17, 0.09) 0.02 (–0.11, 0.15) 0.09 (–0.04, 0.21)
1Values are regression coefficients (95% confidence intervals) that reflect the differences in childhood cardiovascular risk factors per standard deviation score change between the children of
mothers with and without daily vomiting during early pregnancy. Estimates are based on multiple imputed data.
2Basic model is adjusted for child’s sex and age at outcome measurements.
3Confounder models include maternal age, educational level, ethnicity, prepregnancy weight, parity, smoking, folic acid supplement use, diet, delivery mode, and pregnancy complications.
Models for fat mass are additionally adjusted for childhood height.
4Intermediate models are additionally adjusted for each potential intermediate (1. gestational weight gain; 2. birth characteristics: gestational age at birth and birth weight; 3. infant growth:
growth from birth until 2 years of age; 4. infant lifestyle: breastfeeding duration, age at introduction of solid foods, and TV watching).
5Fully adjusted models include all potential confounders and intermediates.
*P < 0.05.
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hospitalization – had a lower gestational age at birth, but not a lower
birth weight.23 Another study among 156,091 mothers in Canada
showed that hyperemesis gravidarum – defined as severe nausea
and vomiting occurring before the 24th gestational week leading
to hospitalization –was associated with an increased risk of preterm
birth, low birth weight, and small size for gestational age.10 Thus,
hyperemesis gravidarum may adversely affect fetal development,
leading to both preterm delivery and low birth weight.
Hyperemesis gravidarum represents the extreme of the spec-
trum of maternal excess vomiting and extreme nausea during
pregnancy. Several studies have shown that other less extreme
measures relating to hyperemesis gravidarum, such as maternal
daily vomiting or severe weight loss, are also associated with an
increased risk of adverse fetal pregnancy outcomes, including
preterm delivery and small size at birth.16–18 Not much is known
about the long-term consequences of maternal hyperemesis grav-
idarum and its related measurements with childhood adiposity
and cardiovascular outcomes. We observed that maternal daily
vomiting during early pregnancy was not associated with a higher
body mass index of the offspring. Our results are in line with a
previous cohort study among 3,165 Dutch mothers and their chil-
dren.18 This study reported that the body mass index at 5 and 6
years of age was similar between the children of mothers with
and without hyperemesis gravidarum, which was measured by
a severe weight loss during early pregnancy.
During childhood, body mass index may not be an accurate
marker of fat mass, as it provides no information on body fat dis-
tribution and cannot distinguish lean mass from fat mass.
Previously we showed that detailed general and abdominal fat
mass measures are, independent of body mass index, associated
with cardiovascular risk factors at school age.39 Similarly, among
adults, waist circumference, as a proxy for abdominal fat mass, is
related to cardiovascular disease and mortality in adulthood,
independent of body mass index.40–42 In the current study, we
observed that maternal daily vomiting during early pregnancy
was associated with a higher childhood total body fat mass,
android/gynoid fat mass ratio, and abdominal preperitoneal fat
mass. To the best of our knowledge, no other studies have exam-
ined these associations yet. Surprisingly, none of these associa-
tions were explained by gestational age or size at birth, even
though both characteristics are known to be related to both gen-
eral and abdominal fat mass in later life.2,43 Our findings were
partly explained by infant growth, a well-known risk factor for
adverse body fat distribution.43,44 Thus, our findings suggest that
the children of mothers with daily vomiting during early preg-
nancy have higher total and abdominal fat mass levels, which
may partly be explained by suboptimal nutrition during fetal life
and compensatory growth acceleration during the postnatal
period.
We did not observe the associations of maternal daily vomit-
ing during early pregnancy with childhood blood pressure and
blood lipids and insulin levels. In contrast, a previous study
among 3,165 Dutch mothers and their children suggested that
maternal hyperemesis gravidarum, defined as a severe maternal
weight loss during early pregnancy, was associated with a higher
blood pressure in childhood, but not with childhood total choles-
terol and triglycerides.18 A study among 78 participants found
that insulin sensitivity was 20% lower in the children of mothers
with severe hyperemesis gravidarum, defined as intractable vom-
iting and electrolyte imbalances during early pregnancy leading
to hospitalization.5 Differences in results might be due to the
use of different measurements relating to hyperemesis gravida-
rum, differences in study populations, and adjustments for con-
founders. Altogether, the results of the present and previous
studies do not suggest consistent associations of maternal vomit-
ing during early pregnancy with offspring cholesterol, triglycer-
ides, and insulin levels.
Underlying mechanisms
The underlying pathophysiology of hyperemesis gravidarum is not
known yet. From an evolutionary adaptation perspective, mild
vomiting during pregnancy may be considered as a defensive
strategy to expel harmful foods or spoiled or teratogenic substan-
ces.6,45–47 However, daily maternal vomiting may also lead to sub-
optimal maternal nutrition, which may subsequently lead to
suboptimal fetal nutrition and developmental adaptations.2
These fetal developmental adaptations may permanently affect
fetal growth, fetal adipocyte development and function, and the
function of cardiovascular organs, predisposing to adverse body
composition and an increased risk of obesity in later life.
Importantly, none of the observed associations of maternal daily
vomiting during early pregnancy with childhood total body and
abdominal fat mass levels were explained by birth characteristics.
This finding is in line with previous studies that focused on
extreme maternal undernutrition, which showed that exposure
to extreme maternal undernutrition during early gestation has
an increased risk of obesity and cardiovascular disease in later life,
independent of size at birth.19,20,48 Together, these findings might
imply that the effects of maternal daily vomiting on offspring’s
body composition may act through other mechanisms than size
at birth, such as alterations in the levels of fetal micronutrients
leading to epigenetic changes or endocrine alterations in the
offspring.18 Further research is needed to obtain more insights
into the causality and underlying mechanisms of the observed
associations.
The effect estimates of the associations of maternal daily vomit-
ing during early pregnancy with childhood total body and abdomi-
nal fat mass levels were small and are mainly of interest from an
etiological perspective. However, since these may be important
from a cardiovascular developmental perspective, their effects
on the risk of cardiovascular disease should be further studied.
Previous studies have shown that childhood body composition
measures tend to track from childhood into adulthood.49–52
A study among 7,723 and 7,252 children aged 7 and 11 years,
respectively, showed moderate tracking of fat mass throughout
childhood.50 A study among 2,204 participants showed a strong
27-year tracking between childhood and adulthood measurements
of body mass index.49 A study among 4,857 children and adoles-
cents, aged 5–20 years, with a median age of 11 years, showed that
childhood obesity was associated with increased rates of premature
death from endogenous causes.51 Similarly, a study among 276,835
Danish schoolchildren showed that a higher childhood BMI across
the full range was associated with an increased risk of coronary
heart disease in adulthood.52 Thus, these studies suggest that even
subclinical differences in childhood fat mass levels are related to
the development of cardiovascular disease in later life. Further
studies are needed to identify the long-term consequences of
maternal hyperemesis gravidarum on offspring’s body fat and
cardiovascular outcomes.
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Conclusions
Our results suggest that maternal daily vomiting during early preg-
nancy is associated with higher childhood total and abdominal fat
mass levels, independent of size or gestational age at birth. Further
studies are needed to replicate these findings, to explore the under-
lying mechanisms, and to assess the long-term consequences.
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